Table 3.
Reference | Equipment (site of measure) | Microvascular measures | Charcot group | Comparison group(s) |
---|---|---|---|---|
Araszkiewicz et al. 2015 [18] | Laser-Doppler (plantar hallux / non-glabrous) |
Thermal peak – Median (IQR) Post-occlusive Reactive Hyperaemia – Median (IQR) |
156 (93–240) 142.5 (98–218) |
DM: 238 (155–300) DM: 143 (98–222) |
Baker et al. 2007 [23] | Laser-Doppler (dorsal foot / glabrous) | Thermal peak – Mean ± SD |
CN: 432 ± 88 CN contralateral foot: 417 ± 110 |
DPN: 262 ± 71 Healthy: 594 ± 94 |
Hamdy et al. 2001 [19] | Laser-Doppler (dorsal foot / glabrous) | ACh Iontophoresis – Median (25th – 75th quartiles) | 227 (86–554) |
DM: 578 (152–1858) DPN: 90 (15–378) DPN and PVD: 74 (1-212) Healthy: 411 (148–641) |
Parkhouse et al. 1988 [20] | Laser-Doppler (plantar foot / non-glabrous) | ACh Iontophoresis – Mean | 3.0 |
Type 1 DM: 12.5 DPN + ulcers: 4.7 DM and skin lesions: 5.8 Healthy: 11.5 |
Shapiro et al. 1998 [24] | Laser-Doppler (dorsal foot / glabrous) |
Thermal AuC – Mean ± SD Thermal vasomotion – Mean ± SD |
64.8 ± 56.9 968.2 ± 450.2 |
DPN: 6.6 ± 1.7 Healthy: 12.9 ± 5.3 DPN: 326.6 ± 176.4 Healthy: 1162.5 ± 279.7 |
Stevens et al. 1992 [21]* | Laser-Doppler (plantar hallux / non-glabrous) | Thermal peak – Mean ± SD |
Acute Charcot 41.0 ± 19.2 CN contralateral foot: 63.4 ± 28.7 |
DM: 62.7 ± 47 DPN + ulcers: 28.9 ± 37.4 Healthy: 76.3 ± 33.9 |
Veves et al. 1998 [22] |
Microspan TcPO2 meter (Dorsal foot / glabrous) Laser-Doppler (dorsal foot) |
Thermal peak – Median (IQR) Post-iontophoresis – Median (IQR) |
94 (57–120) 0.3 (0.2–0.4) |
DM: 119 (76–175) DPN: 71 (35–84) DPN + PVD: 47 (26–64) Healthy: 127 (99–162) DM: 0.5 (0.4–0.7) DPN: 0.3 (0.3–0.4) DPN + PVD: 0.3 (0.3–0.4) Healthy: 0.5 (0.3–0.7) |
IQR, inter-quartile range; DM, uncomplicated diabetes mellitus; CN, Charcot neuroarthropathy; DPN, diabetes-related peripheral neuropathy; PVD, peripheral vascular disease; AuC, area under the curve; TcPO2, transcutaneous oxygen tension